 |
Leucovorin calcium |
|---|---|
| Trade Name | Wellcovorin |
| Orphan Indication | For use in combination with 5-fluorouracil for the treatment of metastatic colorectal cancer |
| USA Market Approval | USA |
| USA Designation Date | 1988-06-23 00:00:00 |
| Sponsor | Glaxo Wellcome Research and Development;5 Moore Drive, PO Box 13398;Research Triangle Park, North Carolina, 27709 |
